The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery
Open accessAbstract
Significant advances in the management of cystic fibrosis (CF) in recent decades have dramatically changed the epidemiology and prognosis of this serious disease, which is no longer an exclusively pediatric disease. This paper aims to review the changes in the incidence and survival of CF and to assess the impact of the discovery of the responsible gene (the CFTR gene) on these changes. The incidence of CF appears to be decreasing in most countries and patient survival, which can be monitored by various indicators, has improved substantially, with an estimated median age of survival of approximately50 years today. Cloning of the CFTR gene 30 years ago and efforts to identify its many mutations have greatly improved the management of CF. Implementation of genetic screening policies has enabled earlier diagnosis (via newborn screening), in addition to prevention within families or in the general population in some areas (via prenatal diagnosis, family testing or population carrier screening). In the past decade, in-depth knowledge of the molecular bases of CF has also enabled the emergence of CFTR modulator therapies which have led to major clinical advances in the treatment of CF. All of these phenomena have contributed to changing the face of CF. The advent of targeted therapies has paved the way for precision medicine and is expected to further improve survival in the coming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
Rommens, J. M., Iannuzzi, M. C., Kerem, B.-S., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N., et al. (1989) · Science · doi:10.1126/science.2772657 · Cited by 3,253
Nährlich, L., Mainz, J. G., Adams, C., Engel, C., Herrmann, G., Icheva, V., Lauer, J., Deppisch, C., Wirth, A., Unger, K., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350071 · Cited by 2,525
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1409547 · Cited by 1,622
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
Welsh, M. J., & Smith, A. E. (1993) · Cell · doi:10.1016/0092-8674(93)90353-r · Cited by 1,485
O'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE: A CLINICAL AND PATHOLOGIC STUDY
ANDERSEN, D. H. (1938) · American Journal of Diseases of Children · doi:10.1001/archpedi.1938.01980140114013 · Cited by 1,146
Prediction of mortality in patients with cystic fibrosis
Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261804 · Cited by 993 · cited 1×
“Beyond the main predictor of worse survival that is lung function (FEV1 < 30% predicted) [62], other factors have been associated with reduced survival such as female sex, higher age at diagnosis, severe CFTR genotype, ethnic background, lower socio-economic status, worse nutritional status, pancreatic insufficiency,…”
BackgroundThe future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation
Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M. P., Dunitz, J. M., Durie, P. R., Sagel, S. D., Hornick, D. B., Konstan, M. W., Donaldson, S. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909825 · Cited by 807
Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Taylor-Cousar, J. L., Munck, A., McKone, E. F., van der Ent, C. K., Moeller, A., Simard, C., Wang, L. T., Ingenito, E. P., McKee, C., Lu, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709846 · Cited by 794
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Kerem, E., Corey, M., Kerem, B.-S., Rommens, J., Markiewicz, D., Levison, H., Tsui, L.-C., & Durie, P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232203 · Cited by 728
VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
Keating, D., Marigowda, G., Burr, L., Daines, C., Mall, M. A., McKone, E. F., Ramsey, B. W., Rowe, S. M., Sass, L. A., Tullis, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1807120 · Cited by 726
Correlation between Genotype and Phenotype in Patients with Cystic Fibrosis
(1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291804 · Cited by 562
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes-Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 535
Genetic Modifiers of Lung Disease in Cystic Fibrosis
Drumm, M. L., Konstan, M. W., Schluchter, M. D., Handler, A., Pace, R., Zou, F., Zariwala, M., Fargo, D., Xu, A., Dunn, J. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051469 · Cited by 504
Recommendations for the classification of diseases as CFTR-related disorders
Bombieri, C., Claustres, M., De Boeck, K., Derichs, N., Dodge, J., Girodon, E., Sermet, I., Schwarz, M., Tzetis, M., Wilschanski, M., et al. (2011) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(11)60014-3 · Cited by 429
Nutritional Benefits of Neonatal Screening for Cystic Fibrosis
Farrell, P. M., Kosorok, M. R., Laxova, A., Shen, G., Koscik, R. E., Bruns, W. T., Splaingard, M., & Mischler, E. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371403 · Cited by 388
Cystic fibrosis in the year 2020: A disease with a new face
De Boeck, K. (2020) · Acta Paediatrica · doi:10.1111/apa.15155 · Cited by 332
CFTR modulator theratyping: Current status, gaps and future directions
Clancy, J. P., Cotton, C. U., Donaldson, S. H., Solomon, G. M., VanDevanter, D. R., Boyle, M. P., Gentzsch, M., Nick, J. A., Illek, B., Wallenburg, J. C., et al. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.05.004 · Cited by 291
Future trends in cystic fibrosis demography in 34 European countries
Burgel, P.-R., Bellis, G., Olesen, H. V., Viviani, L., Zolin, A., Blasi, F., & Elborn, J. S. (2015) · European Respiratory Journal · doi:10.1183/09031936.00196314 · Cited by 282
Corvol, H., Blackman, S. M., Boëlle, P.-Y., Gallins, P. J., Pace, R. G., Stonebraker, J. R., Accurso, F. J., Clement, A., Collaco, J. M., Dang, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9382 · Cited by 278
A survey of newborn screening for cystic fibrosis in Europe
Southern, K. W., Munck, A., Pollitt, R., Travert, G., Zanolla, L., Dankert-Roelse, J., & Castellani, C. (2007) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.05.008 · Cited by 246
Keogh, R. H., Szczesniak, R., Taylor-Robinson, D., & Bilton, D. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.11.019 · Cited by 221
A contemporary survival analysis of individuals with cystic fibrosis: a cohort study
Stephenson, A. L., Tom, M., Berthiaume, Y., Singer, L. G., Aaron, S. D., Whitmore, G. A., & Stanojevic, S. (2015) · European Respiratory Journal · doi:10.1183/09031936.00119714 · Cited by 185
Farrell, P. M., Lai, H. J., Li, Z., Kosorok, M. R., Laxova, A., Green, C. G., Collins, J., Hoffman, G., Laessig, R., Rock, M. J., et al. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.08.012 · Cited by 175
The Estimated Incidence of Cystic Fibrosis in Japan
Yamashiro, Y., Shimizu, T., OGUCHI, S., SHIOYA, T., Nagata, S., & Ohtsuka, Y. (1997) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199705000-00010 · Cited by 155
Newborn Screening for CF across the Globe—Where Is It Worthwhile?
Scotet, V., Gutierrez, H. H., & Farrell, P. M. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6010018 · Cited by 155
Self-citationTHE INCIDENCE OF CYSTIC FIBROSIS
Kosorok, M. R., WEI, W.-H., & Farrell, P. M. (1996) · Statistics in Medicine · Cited by 132
Nick, J. A., Chacon, C. S., Brayshaw, S. J., Jones, M. C., Barboa, C., Clair, C. G. S., Young, R. L., Nichols, D. P., Janssen, J. S., Huitt, G. A., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0092oc · Cited by 127
Mérelle, M. E., Schouten, J. P., Gerritsen, J., & Dankert-Roelse, J. E. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00080101 · Cited by 119
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
Shteinberg, M., & Taylor‐Cousar, J. L. (2020) · European Respiratory Review · doi:10.1183/16000617.0112-2019 · Cited by 115
The changing epidemiology and demography of cystic fibrosis
Stephenson, A. L., Stanojevic, S., Sykes, J. R., & Burgel, P. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.04.012 · Cited by 114
Scotet, V., Braekeleer, M. D., Roussey, M., Rault, G., Parent, P., Dagorne, M., Journel, H., Lemoigne, A., Codet, J.-P., Catheline, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02652-0 · Cited by 110
Self-citationCFTR gene variants, epidemiology and molecular pathology
Bareil, C., & Bergougnoux, A. (2020) · Archives de Pédiatrie · doi:10.1016/s0929-693x(20)30044-0 · Cited by 97
Association Between Carrier Screening and Incidence of Cystic Fibrosis
Castellani, C. (2009) · JAMA · doi:10.1001/jama.2009.1758 · Cited by 96
Lai, H. J., Cheng, Y., & Farrell, P. M. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.08.014 · Cited by 94
Improving transition to adult healthcare for young people with cystic fibrosis: A systematic review
Coyne, I., Sheehan, A., Heery, E., & While, A. (2017) · Journal of Child Health Care · doi:10.1177/1367493517712479 · Cited by 81
Cystic fibrosis survival: the changing epidemiology
Corriveau, S., Sykes, J. R., & Stephenson, A. L. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000520 · Cited by 81
A statistical model to predict one-year risk of death in patients with cystic fibrosis
Aaron, S. D., Stephenson, A. L., Cameron, D. W., & Whitmore, G. A. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.010 · Cited by 78
Female reproductive health in cystic fibrosis
Hughan, K. S., Daley, T. C., Rayas, M. S., Kelly, A. T., & Roe, A. H. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.08.024 · Cited by 78
Lessons learned from 20 years of newborn screening for cystic fibrosis
Massie, J., Curnow, L., Glazner, J. A., Armstrong, D., & Francis, I. (2012) · The Medical Journal of Australia · doi:10.5694/mja11.10686 · Cited by 65
The benefits of newborn screening for cystic fibrosis: The Canadian experience
Mak, D. Y. F., Sykes, J. R., Stephenson, A. L., & Lands, L. C. (2016) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2016.04.001 · Cited by 64
Cystic fibrosis in the Ohio Amish: Gene frequency and founder effect
Klinger, K. W. (1983) · Human Genetics · doi:10.1007/bf00286641 · Cited by 64
Newborn Screening Showing Decreasing Incidence of Cystic Fibrosis
Hale, J. E., Parad, R. B., & Comeau, A. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0707530 · Cited by 63
Scotet, V., Dugueperoux, I., Saliou, P., Rault, G., Roussey, M., Audrézet, M., & Férec, C. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-14 · Cited by 63
Self-citationEarly diagnosis from newborn screening maximises survival in severe cystic fibrosis
Tridello, G., Castellani, C., Meneghelli, I., Tamanini, A., & Assael, B. M. (2018) · ERJ Open Research · doi:10.1183/23120541.00109-2017 · Cited by 60
A 3-year prognostic score for adults with cystic fibrosis
Nkam, L., Lambert, J., Latouche, A., Bellis, G., Burgel, P., & Hocine, M. N. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.03.004 · Cited by 59
Keogh, R. H., Seaman, S. R., Barrett, J., Taylor-Robinson, D. C., & Szczesniak, R. D. (2018) · Epidemiology · doi:10.1097/ede.0000000000000920 · Cited by 58
Audrézet, M., Munck, À., Scotet, V., Claustres, M., Roussey, M., Delmas, D., Férec, C., & Desgeorges, M. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.113 · Cited by 57
Self-citationNeonatal Screening for Cystic Fibrosis: Long-Term Clinical Balance
Mastella, G., Zanolla, L., Castellani, C., Altieri, S., Furnari, M., Giglio, L., Lombardo, M., Miano, A., Sciuto, C., Pardo, F., et al. (2001) · Pancreatology · doi:10.1159/000055856 · Cited by 57
Cystic fibrosis in a low-incidence population: two major mutations in Finland
Kere, J., Estivill, X., Chillón, M., Morral, N., Numes, V., Norio, R., Savilahti, E., & de la Chapelle, A. (1994) · Human Genetics · doi:10.1007/bf00210603 · Cited by 52
Farrell, P. M., Rock, M. J., & Baker, M. W. (2020) · Genes · doi:10.3390/genes11040401 · Cited by 52
Pubertal Height Growth and Adult Height in Cystic Fibrosis After Newborn Screening
Zhang, Z., Lindstrom, M. J., Farrell, P. M., Lai, H. J., & with the Wisconsin Cystic Fibrosis Neonatal Screening Group (2016) · PEDIATRICS · doi:10.1542/peds.2015-2907 · Cited by 44
Declining prevalence of cystic fibrosis since the introduction of newborn screening
Massie, J., Curnow, L., Gaffney, L., Carlin, J. B., & Francis, I. (2010) · Archives of Disease in Childhood · doi:10.1136/adc.2009.172916 · Cited by 39
Sykes, J. R., Stanojevic, S., Goss, C. H., Quon, B. S., Marshall, B. C., Petren, K., Ostrenga, J., Fink, A. K., Elbert, A., & Stephenson, A. L. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.08.026 · Cited by 39
Rubin, J. L., O’Callaghan, L., Pelligra, C. G., Konstan, M. W., Ward, A. J., Ishak, J. K., Chandler, C., & Liou, T. G. (2019) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466618820186 · Cited by 39
Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years
Skov, M., Bækvad‐Hansen, M., HOUGAARD, D. M., Skogstrand, K., Lund, A. M., Pressler, T., Olesen, H. V., & Dunø, M. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24564 · Cited by 38
Influences of environmental exposures on individuals living with cystic fibrosis
Szczesniak, R. D., Rice, J. L., Brokamp, C., Ryan, P., Pestian, T., Ni, Y., Andrinopoulou, E., Keogh, R. H., Gecili, E., Huang, R., et al. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1753507 · Cited by 37
Stafler, P., Mei‐Zahav, M., Wilschanski, M. A., Mussaffi, H., Efrati, O., Lavie, M., Shoseyov, D., Cohen‐Cymberknoh, M., Gur, M., Bentur, L., et al. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.08.007 · Cited by 34
Epidemiology of rare diseases detected by newborn screening in the Czech Republic
David, J., Chrastina, P., Pešková, K., Kožich, V., Friedecký, D., Adam, T., Hlídková, E., Vinohradská, H., Novotná, D., Hedelová, M., et al. (2019) · Central European Journal of Public Health · doi:10.21101/cejph.a5441 · Cited by 32
Genetics of cystic fibrosis: Basics
Férec, C., & Scotet, V. (2020) · Archives de Pédiatrie · doi:10.1016/s0929-693x(20)30043-9 · Cited by 31
Self-citationImpact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France
Scotet, V., Audrézet, M., Roussey, M., Rault, G., Blayau, M., Braekeleer, M. D., & Férec, C. (2003) · Human Genetics · doi:10.1007/s00439-003-0962-0 · Cited by 30
Self-citationGenotype analysis of adult cystic fibrosis patients
Férec, C., Verlingue, C., Gulllermit, H., Quéré, I., Raguénès, O., Feigelson, J., Audrézet, M., Moullier, P., & Mercier, B. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.10.1557 · Cited by 28
Self-citationTo be or not to be on CFTR modulators during pregnancy: Risks to be considered
Vekaria, S., Popowicz, N. D., White, S. W., & Mulrennan, S. A. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.12.004 · Cited by 28
Genetic epidemiology of cystic fibrosis in Saguenay‐Lac‐St‐Jean (Quebec, Canada)
Daigneault, J., Aubin, G., Simard, F., & Braekeleer, M. D. (1991) · Clinical Genetics · doi:10.1111/j.1399-0004.1991.tb03099.x · Cited by 24
Newborn screening for cystic fibrosis in Alberta: Two years of experience
Lilley, M., Christian, S., Hume, S. L., Scott, P., Montgomery, M. D., Semple, L., Zuberbuhler, P. C., Tabak, J., Bamforth, F. J., & Somerville, M. J. (2010) · Paediatrics & Child Health · doi:10.1093/pch/15.9.590 · Cited by 21
A guide to interpreting estimated median age of survival in cystic fibrosis patient registry reports
Keogh, R. H., & Stanojevic, S. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.11.014 · Cited by 21
Keogh, R. H., Bilton, D., Cosgriff, R., Kavanagh, D., Rayner, O., & Sedgwick, P. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213639 · Cited by 21
Cystic fibrosis in black African children in South Africa: a case control study
Owusu, S. K., Morrow, B. M., White, D., Klugman, S., Vanker, A., Gray, D., & Zampoli, M. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.09.007 · Cited by 20
Changing incidence of cystic fibrosis in Wisconsin, USA
Parker‐McGill, K., Nugent, M., Bersie, R., Hoffman, G. L., Rock, M. J., Baker, M. W., Farrell, P. M., Simpson, P. M., & Levy, H. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23265 · Cited by 17
Development and external validation of 1- and 2-year mortality prediction models in cystic fibrosis
Stanojevic, S., Sykes, J. R., Stephenson, A. L., Aaron, S. D., & Whitmore, G. A. (2019) · European Respiratory Journal · doi:10.1183/13993003.00224-2019 · Cited by 11
Cited by
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
Rossi, E., La Rosa, R., Bartell, J. A., Marvig, R. L., Haagensen, J. A. J., Sommer, L. M., Molin, S., & Johansen, H. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00477-5 · Cited by 525
Human temperature regulation under heat stress in health, disease, and injury
Cramer, M. N., Gagnon, D., Laitano, O., & Crandall, C. G. (2022) · Physiological Reviews · doi:10.1152/physrev.00047.2021 · Cited by 491
Ong, T., & Ramsey, B. W. (2023) · JAMA · doi:10.1001/jama.2023.8120 · Cited by 315
O'Hayer, C. V., Smith, P. J., Drescher, C. F., Bruschwein, H., Nurse, C. N., Kushner, H. M., Ingle, K., Stephen, M. J., & Hoag, J. B. (2024) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2024.11.011 · Cited by 12
The Lived Experience of Jordanian Parents of Children with Cystic Fibrosis: Qualitative Study
AlAdaileh, A. G., Obeidat, H. M., Khamaiseh, A., AlNawafleh, A. H., Mahasneh, D., & Froelicher, E. S. (2021) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2021.04.028 · Cited by 12
Metadata
- Authors
- Scotet, V., L’Hostis, C., & Férec, C.
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2020-05-26
- Volume
- 11
- Issue
- 6
- Pages
- 589
- ISSN
- 2073-4425 (ISSN-L)
- OpenAlex
- W3030182832
- Cited by
- 317
- References
- 76
- FWCI
- 20.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.